Moderate riskFDA DrugClass III

American Health Packaging buprenorphine recalled for label mix-up

American Health Packaging distributed buprenorphine sublingual tablets with incorrect labeling. The affected medication is a prescription opioid used to treat pain and opioid use disorder. A label mix-up could result in dosing errors if patients or healthcare providers rely on incorrect information.

From the FDA notice · Read the official notice ↗ · All American Health Packaging recalls

What to do

  1. Check if your buprenorphine matches Lot #1030023 with expiration date 06/30/2027 and NDC #60687-481-21.
  2. Do not use affected tablets without speaking to your pharmacist or doctor first.
  3. Contact your pharmacy or healthcare provider for guidance on obtaining correctly labeled medication.
  4. Do not stop taking buprenorphine abruptly without medical supervision.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).
Sold in
Nationwide
Made for
Adults

Details

Units affected
10,953 cartons.
Illnesses reported
None reported
Manufactured in
2550 John Glenn Ave Ste A, N/A, Columbus, OH, United States
Classification
Class III
Recall number
D-0840-2026

In the FDA's words

Description
Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11). Labeling: Label Mix-up Lot # 1030023, Exp Date: 06/30/2027. Distribution: US Nationwide. Affected quantity: 10,953 cartons.
Hazard
Labeling: Label Mix-up

More from American Health Packaging

See all

Related topics

Label mix upDrugsSold nationwideMore from FDA Drug